Egypt Medical Device Classification: Class I–III and IVD A–D

1. Key takeaways

Egypt applies two classification scales in parallel. Medical devices are classified as Class I (subdivided into non-sterile and sterile), Class IIa, Class IIb, and Class III, while in vitro diagnostic devices (IVDs) are separately classified into Class A, B, C, and D. On the evidentiary side, Annex X of the import approval guideline expressly follows the established rules of the European Communities and issues certificate requirements by classification combination, while the vigilance guideline sets the intensity of periodic reporting according to IVD Classes B, C, and D. The two symbol systems must never be mixed: a device never receives an A–D class, and an IVD never receives a I–III class. Because classification drives certificate combinations, CE requirements, Scientific Committee referral, and post-market reporting frequency all at once, it is the single most consequential regulatory attribute of a product in Egypt and should be fixed early in the market-entry plan.

2. Legal basis

3. Expert insights

Insight 1: the split of Class I into non-sterile and sterile is not a drafting accident but a watershed.

Annex X of the import approval guideline lists Class I in two rows. Class I non-sterile requires only a declaration of conformity or a free sale certificate, whereas Class I sterile requires a declaration of conformity plus a free sale certificate. The classification is identical, but the certificate combination differs. This shows that Egypt treats sterility as a management dimension running parallel to risk class, not as a mere labelling attribute. Two products of the same technical family can therefore face different document obligations purely because one is supplied sterile, and the sterile attribute should be recorded as a distinct field in every internal regulatory database.

Insight 2: classification directly determines both the CE certificate question and the Scientific Committee question.

The gradient in Annex X runs as follows: Class I non-sterile carries no CE requirement, Class I sterile carries no CE requirement, Class IIa requires a CE certificate, and Class IIb and Class III require CE certificates. On top of that, Class IIb and Class III devices whose country of origin is not a reference country must first pass a dedicated Scientific Committee evaluation. The higher the class, the heavier the evidence and the longer the pathway. Companies holding high-class portfolios should treat classification as the master variable in their Egypt timeline, because it simultaneously controls documentation, cost, and queue time.

Insight 3: the A–D scale for IVDs mainly shapes post-market intensity, not only the registration dossier.

The vigilance guideline ties periodic reporting obligations to the IVD class. Class A (or equivalent) IVDs only prepare a PMSR, provided on demand, while Class B, C, and D (or equivalent) must submit a PSUR, and Classes C and D must be updated at least annually. In other words, the IVD class determines the holder’s reporting frequency for the entire life of the authorization. A one-step difference in class translates into years of recurring reporting work, so the classification decision deserves the same scrutiny as the registration pathway itself.

Insight 4: classification is not self-declared by the company; it is re-checked against the evidence.

The registration guideline provides that devices must submit a free sale certificate from a reference country, and that where the country of manufacture is not a reference country, a free sale certificate from a reference country must additionally be submitted, with Class IIb and III devices requiring the reference-country FSC. This means the declared classification will be cross-checked against the classification stated on the reference-country approval certificate. If the certificate shows a different class than the one declared in Egypt, the discrepancy will surface during review and can derail the application, so internal classification records should always cite the source certificate.

Insight 5: classification differences can break up the plan of a single registration number.

Section 11.1 of the registration guideline provides that multiple devices sharing one registration number must share, among other elements, the classification. Devices classified differently cannot be merged into a single registration number and must obtain certificates separately. Portfolio consolidation strategies should therefore be tested against classification before submission, because a grouping that looks economical on paper may be impossible to register as a unit.

4. Practical recommendations

1. Fix the symbol system before fixing the level: devices use I / IIa / IIb / III and IVDs use A / B / C / D, and the two systems must never be mixed in any document.
2. Verify the class against the certificates: treat the classification stated on the reference-country FSC or the CE certificate as the primary evidence for the declared class.
3. Track sterility as a separate field: Class I sterile and Class I non-sterile carry different certificate combinations, so the attribute needs its own data point.
4. Budget post-market cost by class: Class IIb and III devices and IVD Classes C and D require a PSUR updated at least annually, which is a recurring cost line.
5. Check classification before merging registrations: devices of different classes cannot share one registration number, so test each grouping against this rule first.

5. Verification checklist

• □ Confirmed whether the product is a device (I / IIa / IIb / III) or an IVD (A / B / C / D)
• □ Confirmed the certificate combination for that class under Annex X
• □ Recorded the sterile or non-sterile attribute separately and checked the certificate difference
• □ Obtained a reference-country FSC or CE certificate stating the classification
• □ Estimated periodic reporting obligations and frequency by class
• □ Confirmed identical classification across all products before merged registration

Regulatory information verified as of October 29, 2026. The classification scales and certificate combinations described in this article follow the current texts of EDREX: GL.CAMD.007 Annex X, GL.CAP.Care.040, and GL.CAMD.002; when the guidelines are revised, the content must be re-checked.

• Local Egypt support: GRZAN assists manufacturers from the Chinese mainland and overseas with medical device registration, import approval, and change applications before the Egyptian Drug Authority (EDA), including design of the registration applicant structure (importing company, local factory, or scientific office), preparation for Scientific Committee evaluation, advisory work on pathways for obtaining free sale certificates from reference countries, Arabic localization of labels and instructions for use, and the build-out of vigilance systems and periodic reporting.
• Service capabilities: product characterization and risk classification (devices Class I–III and IVDs Class A–D), registration and re-registration, determination of applicability of system registration and group registration, three-category determination of changes, import approval and annual import plans, and support for vigilance reports and field safety corrective actions.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.